FdaApplication

ANDA 209488

Back to search

Identifiers

Properties

PropertyValue
applicant_nameZYDUS PHARMACEUTICALS USA INC
application_typeANDA
approval_date2022-09-29

Products (2)

ProductActive ingredientStrengthDosage form
MIRABEGRONMIRABEGRON25MGTABLET, EXTENDED RELEASE;ORAL
MIRABEGRONMIRABEGRON50MGTABLET, EXTENDED RELEASE;ORAL

2 products